rs693335
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1
The NM_000504.4(F10):c.231+517G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 193,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00039 ( 0 hom. )
Consequence
F10
NM_000504.4 intron
NM_000504.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.59
Publications
3 publications found
Genes affected
F10 (HGNC:3528): (coagulation factor X) This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000386 (17/44006) while in subpopulation NFE AF = 0.000603 (16/26534). AF 95% confidence interval is 0.000378. There are 0 homozygotes in GnomAdExome4. There are 10 alleles in the male GnomAdExome4 subpopulation. Median coverage is 0. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| F10 | NM_000504.4 | c.231+517G>A | intron_variant | Intron 2 of 7 | ENST00000375559.8 | NP_000495.1 | ||
| F10 | NM_001312674.2 | c.231+517G>A | intron_variant | Intron 2 of 6 | NP_001299603.1 | |||
| F10 | NM_001312675.2 | c.231+517G>A | intron_variant | Intron 2 of 7 | NP_001299604.1 | |||
| F10-AS1 | NR_126424.1 | n.-83C>T | upstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F10 | ENST00000375559.8 | c.231+517G>A | intron_variant | Intron 2 of 7 | 1 | NM_000504.4 | ENSP00000364709.3 |
Frequencies
GnomAD3 genomes AF: 0.000207 AC: 31AN: 149486Hom.: 0 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
31
AN:
149486
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000386 AC: 17AN: 44006Hom.: 0 Cov.: 0 AF XY: 0.000443 AC XY: 10AN XY: 22588 show subpopulations
GnomAD4 exome
AF:
AC:
17
AN:
44006
Hom.:
Cov.:
0
AF XY:
AC XY:
10
AN XY:
22588
show subpopulations
African (AFR)
AF:
AC:
0
AN:
762
American (AMR)
AF:
AC:
0
AN:
3452
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
814
East Asian (EAS)
AF:
AC:
0
AN:
2648
South Asian (SAS)
AF:
AC:
0
AN:
5554
European-Finnish (FIN)
AF:
AC:
0
AN:
1736
Middle Eastern (MID)
AF:
AC:
0
AN:
168
European-Non Finnish (NFE)
AF:
AC:
16
AN:
26534
Other (OTH)
AF:
AC:
1
AN:
2338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000207 AC: 31AN: 149486Hom.: 0 Cov.: 35 AF XY: 0.000178 AC XY: 13AN XY: 73070 show subpopulations
GnomAD4 genome
AF:
AC:
31
AN:
149486
Hom.:
Cov.:
35
AF XY:
AC XY:
13
AN XY:
73070
show subpopulations
African (AFR)
AF:
AC:
0
AN:
39078
American (AMR)
AF:
AC:
0
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5148
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
5
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
AC:
26
AN:
67918
Other (OTH)
AF:
AC:
0
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.